Keppler and colleagues show that individuals with hematological cancers rapidly develop potent infection-neutralizing antibodies and a robust T cell response against several SARS-CoV-2 variants of concern in response to mRNA vaccination.
- Andrea Keppler-Hafkemeyer
- Christine Greil
- Oliver T. Keppler
